Skip to content

Hemodynamics during compression therapy

Hemodynamics during compression therapy in the prevention of drug-induced peripheral neuropathy.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1050220161
Enrollment
10
Registered
2023-01-30
Start date
2023-06-01
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer Chemotherapy, Drug induced peripheral neuropathy

Interventions

Perform hand and finger compression using a test instrument that can control the compression pressure.

Sponsors

Mori Yukiko]
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Age at the time of consent is at least 18 years old 2) PS (ECOG) of either 0-1 3) Written consent to participate in the study has been obtained from the patient

Exclusion criteria

Exclusion criteria: 1) Undergoing chemotherapy with anticancer age nts 2) Participants with any of the following complications 1) Peripheral neuropathy causing problems in daily life (CTCAE Grade 2 or higher) 3) Participants with any of the following 1) Has a history of vascular disease or other conditions that cause peripheral circulatory disturbance (e.g., cerebrovascular disease, ASO, thrombosis, diabetes mellitus) 4) Participants whom the principal investigator or research assistant determines to be unsuitable for the safe conduct of this study.

Design outcomes

Primary

MeasureTime frame
Haemodynamics during compression.

Secondary

MeasureTime frame
Symptoms during compression.

Contacts

Public ContactYukiko Mori

Kyoto University Hospital

yukimori@kuhp.kyoto-u.ac.jp+81-75-751-4349

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026